IPO Trending
ZENITHDRUGSME / NSEListed

Zenith Drugs Limited

Zenith Drugs Limited, founded in 2000, is a pharmaceutical company that manufactures and trades affordable, high-quality medicines, including various generic products. The company operates under WHO-GMP guidelines and holds an ISO 9001:2015 certification, reflecting its focus on quality. It offers a wide product range such as ORS powder, liquid orals, ointments, liquid externals, and capsules, with over 600 products approved by the Food & Drugs Administration and 325 currently in production. Zenith Drugs is expanding by setting up a new manufacturing facility in Muradpura, Depalpur, Indore, and it also exports its products to multiple regions including Central America, Africa, Southeast Asia, and South Asia. The company provides third-party manufacturing services to well-known pharmaceutical brands like Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, and as of March 31, 2023, it employs 89 people, including both payroll and contract staff.

₹75 - ₹79179.07x sub
Listed Price110.00
Listing Gain+39.24%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Sep-23)6948.43 Cr
Growth-25.0%
Revenue Trend (₹ in Crores)
0.04.4k8.9k13.3kMar-22Mar-23Sep-23
PeriodRev (Cr)PAT (Cr)AssetsDebt
Sep-236,948.43539.3811,249.042,902.81
Mar-2311,569.65515.299,793.832,605.03
Mar-229,266.63312.866,858.471,880.86
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
20234.2935.13%37.29%18.45.5
20222.6229.83%30.08%00
20212.5240.73%36.52%00